AT-1965

N/A

Report date: 2024/12/16 14:15:59
NME

Base Information

Drug NameAT-1965
Drug Alias NameAT-1965
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 inhibitors
TargetsCap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAkamara Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlyssum Therapeutics
Inactive CompaniesAkamara Therapeutics Inc
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A